Stay Connected. Stay Informed.
Business
Globally, gold and silver futures were trading flat at $3,768.50 per ounce and $44.19 per ounce, respectively. | Photo Credit: Reuters Gold prices eased by ₹125 to ₹1,12,430 per 10 grams in the domestic futures market on Thursday, tracking a flat trend overseas as traders stayed cautious ahead of key U.S. inflation data. On the…
Representational image only. File The Directorate General of Foreign Trade (DGFT) has restricted the import of plain silver jewellery unless expressly authorised in a bid to curb misuse of India’s various Free Trade Agreements, the government announced. An analysis by The Hindu found most of these imports were coming from Thailand. The notification was issued…
The Union Cabinet on Wednesday (September 24, 2025) approved a ₹69,725 crore package to revitalise India’s shipbuilding and reduce dependence on foreign ships as part of the government’s plan to regain the country’s maritime power. According to an official statement, the package introduces a four-pillar approach designed to strengthen domestic capacity, improve long-term financing, promote…
Read More “Cabinet approves ₹69,725 crore package to revitalise shipbuilding, maritime ecosystem” »
A view of the National Stock Exchange building in Mumbai. | Photo Credit: Getty Images/iStockphoto Equity benchmark indices Sensex and Nifty declined in early trade on Thursday (September 25, 2025) as relentless foreign fund outflows and U.S. H-1B visa fee concerns made investors jittery. Also, a weak trend in global peers drove the domestic equity…
Image used for representation purpose only. | Photo Credit: Getty Images/iStockphoto The rupee recovered 15 paise from all-time low to 88.60 against the U.S. dollar in early trade on Thursday (September 25, 2025), tracking the weakness of the American currency in the overseas market. Forex traders said the rupee is facing renewed strain this week,…
Read More “Rupee recovers 15 paise from all-time low to 88.60 against U.S. dollar in early trade” »
Nutanix and Lenovo have deepened their partnership in India to deliver AI-ready, enterprise cloud infrastructure tailored to local needs. Nutanix, which is into hybrid multicloud computing, and Lenovo Group Ltd on Tuesday (September 23, 2025) announced a significant deepening of their collaboration in India, to deliver advanced enterprise cloud and AI solutions suited to India’s…
Read More “Lenovo, Nutanix deepen alliance to deliver AI-ready cloud infra in India” »
Capri Global Capital Ltd has announced public issue of secured, rated, listed, redeemable non-convertible debentures (NCDs) of face value of ₹1,000 each for an amount of ₹200 crore (base issue size) with an option to retain oversubscription up to an amount of ₹200 crore(green shoe option) aggregating up to ₹400 crore. The NCDs offer the…
Read More “Capri Global to raise upto ₹400 crore via NCD issue ” »
Sudhanshu Vats, Managing Director of Pidilite Industries Limited. File | Photo: X/@Sudhanshu_Vats Sudhanshu Vats, Managing Director, Pidilite Industries Limited, has been named the new chairman of the Advertising Standards Council of India (ASCI) at its 39th annual general meeting (AGM). With ASCI, India’s self-regulatory body for advertising, completing 40 years in October, the appointment comes…
Chennai based Glottis Limited, which offers multi-modal integrated logistics solutions, has announced to tap the capital market to raise upto ₹160 crore through a fresh issue of its equity shares and ₹147 crore via Offer for Sale (OFS) by Ramkumar Senthilvel and Kuttappan Manikandan, the Promoter Selling Shareholders. The price band has been fixed between ₹120-₹129 per equity…
Read More “Glottis Limited fixes IPO price band at ₹120-₹129 per share” »
Generic drugmaker Lupin has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Bictegravir, Emtricitabine and Tenofovir Alafenamide Tablets, 50 mg/200 mg/25 mg. The tablets are bioequivalent to Gilead Sciences Biktarvy Tablets, 50 mg/200 mg/25 mg and indicated for treatment of human immunodeficiency virus infection in…
Read More “U.S. FDA nod for Lupin’s copy of Gilead Sciences’ HIV drug ” »
